Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 93 for “"CLL"”.
-
Analysis of the Tumour Microenvironment in CLL
… systems in Chronic Lymphocytic Leukaemia (CLL).CLL is a cancer of the blood which affects B cells. CLL cells accumulate quickly in the body but die rapidly by apoptosis when cultured in the lab, suggesting that CLL cell survival can be modulated by tumour cell interactions with the …
-
Two-Stage Multi-Channel LED Driver with CLL Resonant Converter
… stage and a multi-channel constant current (MC3) CLL resonant converter as the second stage. For the CLL resonant converter, the magnetizing inductance of the transformer can be as large as possible. Therefore, the magnetizing current of the transformer has little influence on the output currents. …
-
Entwicklung von GM-CSF-produzierenden EBV-Vektoren für die Immuntherapie der B-CLL
… Zytokin GM-CSF in Tumorzellen von B-CLL-Patienten (Chronische lymphatische Leukämie) exprimieren. Dabei entscheidend ist die Eigenschaft von EBV naive, wie auch reife und maligne B-Lymphozyten über den CD21-Rezeptor spezifisch zu infizieren. Als Grundlage diente das Maxi-EBV-System, …
-
The expression and signalling patterns of CD180 toll like receptor in Chronic Lymphocytic Leukaemia (CLL)
Chronic lymphocytic leukaemia (CLL) is characterised by a progressive accumulation of mature CD5+CD20+CD23+ lymphocytes. Despite the remarkable progress in our understanding of the immunobiology of CLL, the aetiology of the disease remains unknown. The consensus is that CLL cells are driven by …
-
Cll Metabolism Is Regulated By Prognostic Factors, Modulated By Stroma and Abrogated By Pi3K Inhibition
<p>Metabolism of chronic lymphocytic leukemia (CLL), a disease characterized by the relentless accumulation of mature B cells has been little explored. Bone marrow stromal cells provide a survival benefit to CLL cells, in part through PI3K/AKT pathway. Compared with proliferative B-cell lines, …
-
Analysis of Periodic and Random Capacitively-Loaded Loop (CLL) Metamaterial Structures for Antenna Enhancement Applications
… a periodic array of capacitively-loaded loop (CLL) inclusions paired with continuous wire results in negative refraction, this study performs numerical simulations to characterize random metamaterial structures. These structures consist of CLLs that are randomized in both position and …
-
Correlazione tra dati biologici e prognosi in pazieti affetti da B-CLL in stadio A secondo Binet
… e dell'overall survival nei pazienti affetti da CLL in stadio iniziale. La maggioranza di questi markers prognostici ,anche se ormai in uso quotidiano nella pratica clinica, non è ancora incluso nelle linee guida internazionali che si basano ancora su criteri esclusivamente clinici e individuano …
-
Untersuchungen zur Signaltransduktion des CXCR4 (CD 184) Chemokinrezeptors im Hinblick auf Vitalität und Migration humaner B-CLL-Zellen
Die Chronische Lymphatische Leukämie (B-CLL) ist eine lymphoproliferative Erkrankung, bei der es charakteristischerweise zu einer Akkumulation von langlebigen CD5+, CD19+, CD23+ B-Lymphozyten im Blut, im sekundären lymphatischen Gewebe und im Knochenmark kommt. Akzessorische Zellen im Knochenmark …
-
Functional role of ZAP70 in Chronic Lymphocytic Leukaemia
Chronic lymphocytic leukaemia (CLL) is the most common type of leukaemia. It is common in older people and rare in people under 40. CLL is characterised by the accumulation of monoclonal CD5+CD23+ B lymphocytes in the blood, bone marrow and secondary lymphatic tissues. There are 2 main subtypes of …
-
Targeting The Redox System to Overcome Mechanisms of Drug Resistance In Chronic Lymphocytic Leukemia
<p>Chronic Lymphocytic Leukemia (CLL) is the most common form of leukemia diagnosed in Western countries and is characterized by clonal expansion of B cells. The clinical course of CLL is diverse and nearly 50% of patients present with chromosomal abnormalities. Deletion of the short arm on …
-
CD200: A Novel Therapeutic Target for Chronic Lymphocytic Leukemia
… blockade of CD200 on lymphoma cells or primary CLL cells, both of which express CD200 at high levels, augmented cytotoxic killing of these cells by effector CD8+ T cells in vitro. We also identified and characterized a previously unrecognized soluble form of CD200, sCD200, present in elevated …
-
Functional interaction between CD180 Toll-like receptor (TLR) and B cell receptor (BCR) in the biology of Chronic Lymphocytic Leukaemia (CLL)
Chronic Lymphocytic Leukaemia (CLL) is the most common leukaemia in the western world and remains incurable. It is driven by as yet unknown (auto)antigens via the B cell receptor (BCR) and growth, survival and expansion signals it receives from the microenvironment through a range of cytokines and …
-
CD180/RP105 Toll-like Receptor (TLR) mediated signalling in Chronic Lymphocytic Leukaemia
… progression of chronic lymphocytic leukaemia (CLL) is currently of major interest. Pathogen- and damage-associated molecular patterns (PAMPs and DAMPs, respectively) represent exogenous and endogenous microenvironmental factors acting via a range of receptors, including Toll-like receptors …
-
Understanding the biology of CD180 in chronic lymphocytic leukemia
… expressed on chronic lymphocytic leukaemia (CLL) cells from different patients. The loss of CD180 in CLL indicates that the receptor somehow confers a survival advantage for the tumour. In support of this, we found that CD180 expression was enriched in CLL cases with mutated immunoglobulin …
Page 1 of 5